INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,148,000 | -40.0% | 7,000,000 | -44.4% | 0.22% | -37.5% |
| Q4 2018 | $11,906,000 | -21.3% | 12,600,000 | -7.4% | 0.35% | -1.9% |
| Q3 2018 | $15,130,000 | +19.2% | 13,600,000 | +7.9% | 0.36% | +40.8% |
| Q2 2018 | $12,692,000 | +86.3% | 12,600,000 | +80.0% | 0.26% | +131.8% |
| Q1 2018 | $6,812,000 | – | 7,000,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 10,200,000 | $6,453,000 | 0.96% |
| Springhouse Capital Management, LP | 2,000,000 | $1,215,000 | 0.48% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 9,700,000 | $5,784,000 | 0.40% |
| Telemetry Investments, L.L.C. | 1,000,000 | $596,000 | 0.28% |
| Bruce & Co., Inc. | 2,000,000 | $1,200,000 | 0.27% |
| DAFNA Capital Management LLC | 600,000 | $369,000 | 0.26% |
| Orbimed Advisors | 7,000,000 | $4,261,000 | 0.04% |
| Baker Brothers Advisors | 5,000,000 | $2,978,000 | 0.03% |
| Citadel Advisors | 8,500,000 | $5,143,000 | 0.00% |
| DEUTSCHE BANK AG\ | 3,000,000 | $1,788,000 | 0.00% |